Grant: CIHR Fellowship
Direct Payment
$112,500.00
A novel approach towards understanding the functional biology of the neuronal ceroid lipofuscinosis (NCL) protein CLN3
EF 2012-13
Résumé
Batten disease is the most common neurodegenerative disorder to affect children. The central nervous system is the most dramatically affected organ where neuronal dysfunction leads to vision loss, epilepsy, progressive mental retardation, and a reduced lifespan. Batten disease results from mutations in the CLN3 gene, which encodes a transmembrane protein of unknown function. The high conservation of CLN3 from yeast to human has allowed for studies of the protein in simple model organisms, yet the precise function of CLN3 remains incompletely understood. The purpose of my research is to determine the normal function of CLN3. I will create genetic models of mutations and knock-out the gene in the model organism Dictyostelium and then study how the loss-of-function causes defects at the cell and multicellular level. In this organism there is a single CLN3 gene that is highly similar to human. Dictyostelium cells display remarkably similar biological behaviors to mammalian cells and this model organism has been used with great success to study other proteins that cause neurodegeneration (e.g. Huntington's, Alzheimer's, and Parkinson's disease). By creating a new biomedical model system deficient for CLN3, I will be able to characterize the resulting defects with unparalleled cellular clarity, given the well defined cell biology and unique life cycle of Dictyostelium. I can then introduce the human CLN3 protein into these cells to assess rescue of defects and can also introduce human CLN3 proteins that contain different mutations to study how these mutations specifically affect its function. Understanding the functionality of CLN3 and the effect of CLN3 mutations will significantly advance our knowledge of the biological pathways that are affected in Batten disease.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
269686
Name
Huber Robert J
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
A novel approach towards understanding the functional biology of the neuronal ceroid lipofuscinosis (NCL) protein CLN3
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$112,500
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Batten Disease; Cell Biology; Cln3; Dictyostelium Discoideum; Induced Pluripotent Stem Cells; Knockout Mutant; Molecular Biology; Neurodegeneration; Neuronal Ceroid Lipofuscinosis; Translational Research
Abstract
Batten disease is the most common neurodegenerative disorder to affect children. The central nervous system is the most dramatically affected organ where neuronal dysfunction leads to vision loss, epilepsy, progressive mental retardation, and a reduced lifespan. Batten disease results from mutations in the CLN3 gene, which encodes a transmembrane protein of unknown function. The high conservation of CLN3 from yeast to human has allowed for studies of the protein in simple model organisms, yet the precise function of CLN3 remains incompletely understood. The purpose of my research is to determine the normal function of CLN3. I will create genetic models of mutations and knock-out the gene in the model organism Dictyostelium and then study how the loss-of-function causes defects at the cell and multicellular level. In this organism there is a single CLN3 gene that is highly similar to human. Dictyostelium cells display remarkably similar biological behaviors to mammalian cells and this model organism has been used with great success to study other proteins that cause neurodegeneration (e.g. Huntington's, Alzheimer's, and Parkinson's disease). By creating a new biomedical model system deficient for CLN3, I will be able to characterize the resulting defects with unparalleled cellular clarity, given the well defined cell biology and unique life cycle of Dictyostelium. I can then introduce the human CLN3 protein into these cells to assess rescue of defects and can also introduce human CLN3 proteins that contain different mutations to study how these mutations specifically affect its function. Understanding the functionality of CLN3 and the effect of CLN3 mutations will significantly advance our knowledge of the biological pathways that are affected in Batten disease.
Competitiondate
201210
Approvedterm2
2 yrs 3 mths
Pinamesdelim
Huber, Robert J
Approvedterm
2 ans 3 mois
Cihrcontribution2
~ $112,500~ $0~